Home › Gastrointestinal Cancers › North Carolina
Gastrointestinal Cancers clinical trials in North Carolina
11 studies for Gastrointestinal Cancers are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Charlotte
- GSK Investigational Site, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07218926The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
- Flora Danquah, Chapel Hill
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04700527Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
- Wake Forest NCORP Research Base, Winston-Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07215624Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Duke Cancer Center Cary, Cary
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Duke University Medical Center, Durham
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Durham
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06885034Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
- USA01-0, Huntersville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT07263594Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT05743426From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.